Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

95.36 +0.33 (+0.35%)
Streaming Delayed Price Updated: 3:58 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cardinal Health

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Cardinal Health's Outcomes Business Merges With Transaction Data Systems, Marking New Chapter
Via Benzinga
7 Overvalued Blue-Chip Stocks to Sell Before June 2023
For a variety of reasons, there are several blue-chip stocks to avoid in this market. Here are seven overvalued blue-chip stocks to sell now. 
Via InvestorPlace
Shhh! 3 Healthcare Stocks Quietly Hitting 52-Week Highs
Investors are busy looking at tech stocks, but they should be looking for healthcare stocks to buy, as this group powers to new highs. 
Via InvestorPlace
Chart Of The Day: Cardinal Health - The Right Prescription
Revenue is expected to grow 12.60% this year and another 6.50% next year. Earnings are estimated to increase by 13.00% this year, and an additional 13.50% next year. 
Via Talk Markets
Dividend Income Update April 2023
With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated. 
Via Talk Markets
What 7 Analyst Ratings Have To Say About Cardinal Health
Via Benzinga
The Latest Analyst Ratings for Cardinal Health
Via Benzinga
After 300% Climb, McKesson Stock Earns Bullish Strength Rating
McKesson stock rose in a steep upward incline from a low of 106.11 at the end of December 2018 to a 401.78 all-time high on Nov. 4 last year. 
Via Investor's Business Daily
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
Cardinal Health Q3 Earnings Beats Estimates On Pharmaceutical Segment Strength, Raises Annual Profit Forecast
Via Benzinga
US Stocks Set For Mixed Open As Banking Jitters Dampen Apple Earnings Buzz: Analyst Advises 'Cautious Optimism'
With so much going on in the banking space, sentiment continues to remain jittery. The index futures point to a mixed opening on Thursday, as the tech space exuded optimism ahead of Apple, Inc.’s... 
Via Benzinga
7 Dividend Aristocrats to Buy for Long-Term Income
These dividend aristocrats are the best stocks to buy for long-term income generation and lower portfolio risk. 
Via InvestorPlace
AmerisourceBergen Stock Joins Elite Group Of Top Performers
The 82 Relative Strength Rating shows that AmerisourceBergen stock outperformed 82% of all stocks over the past 12 months. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Best Performing Blue Chip Stocks
While there may be varying interpretations among investors, the term “blue chip” typically denotes companies that are regarded as leaders in their respective fields. 
Via Talk Markets
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
McKesson Stock Strength Rating Jumps To 81; Strong Start To '23
McKesson stock shows rising price performance earning it an upgrade to its IBD Relative Strength Rating, from 73 to 81. 
Via Investor's Business Daily
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
Medical stocks are holding up amid economic and market uncertainty. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
This Dividend-Focused ETF Is Not a Good Dividend Investment
Invesco Dividend Achievers ETF buys companies that reliably increase their dividends, which is also why it's not a great dividend investment. 
Via The Motley Fool
Is It Too Late to Buy McKesson Stock?
The healthcare supplier has seen its shares climb 15% over the past year. 
Via The Motley Fool
Don't Wait for Your Dividends. Here's How You Can Collect Cash Every Month.
These stocks all pay more than what you'd get with the average stock on the S&P 500. 
Via The Motley Fool
3 Inflation-Resistant Businesses That Recently Raised Guidance
These stocks can be relatively safe places to invest in if you're worried about inflation. 
Via The Motley Fool
7 Stocks Set to Soar When the Market Recovers
Daring contrarians can bid up the danger with these intriguing market ideas. 
Via InvestorPlace
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? 
Via News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. 
Via Benzinga
This Stock Could Fill Your Pockets for Years to Come
$273 billion in sales from a company you've probably never heard of. 
Via The Motley Fool
3 Great Value Stocks To Buy Now For Steady Long-Term Growth
We explore three highly-ranked value stocks with resilient businesses—CAH, GPK and BJ—that investors might want to consider buying amid lingering inflation. 
Via Talk Markets
Is This Warren Buffett Stock a Buy for Dividend Growth Investors?
This Buffett-backed business leads the medical distribution industry. 
Via The Motley Fool
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.